GeminIQ Website Logo

Viewing CLPT free

Subscribe for full history, 90+ metrics, screener, watchlist...

ClearPoint Neuro, Inc.

CLPT

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
293646384212202233352324
Short Term Investments
----------00
Accounts Receivable Net Current
897444543332
Inventory Net
998767778889
Prepaid Expense And Other Assets Current
223322222222
Assets Current
495564515424333447483637
Property Plant And Equipment Net
333222222111
Operating Lease Right Of Use Asset
13138663333344
Inventory Noncurrent
-----0000000
Indefinite Lived Contractual Rights
-----0011111
Goodwill
777---0-----
Intangible Assets Net Excluding Goodwill
131314---0-----
Other Assets Noncurrent
222110100000
Assets
879398606330394053544344
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
221121111101
Employee Related Liabilities Current
434432543232
Other Accrued Liabilities Current
223212111111
Operating Lease Liability Current
001001111000
Contract With Customer Liability Current
2222122-----
Deferred Revenue Current
------211131
Convertible Notes Payable Current
--------1010--
Liabilities Current
10911877108171576
Operating Lease Liability Noncurrent
14148663333344
Deferred Revenue Noncurrent
------000011
Contract With Customer Liability Noncurrent
1111100-----
Long Term Notes Payable
5050492929-0-----
Secured Long Term Debt
------00001010
Deferred Income Tax Liabilities Net
000---0-----
Other Liabilities Noncurrent
1100--0-----
Liabilities
767570444310141120192120
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
246239239225223217216215213211193192
Common Stock Shares Subscriptions
366---0-----
Retained Earnings Accumulated Deficit
-238-226-217-209-203-197-191-186-181-177-172-168
Stockholders Equity
111928162020252932352124
Liabilities And Stockholders Equity
879398606330394053544344
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
252525252525252525252525
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
909090909090909090909090
Common Stock Shares Issued
313029282828282828272525
Shares Outstanding
313029282828282828272525

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20265.74%53.57%22.56%---------
2025-1.90%-17.61%-29.58%4.84%159.77%120.30%-20.68%-23.09%-13.99%-22.22%14.87%15.50%
2024-7.81%-8.49%25.47%101.55%73.76%102.48%-7.82%17.36%33.01%-22.30%-28.92%-23.46%
2023----10.31%-21.72%-19.06%9.78%25.28%28.78%6.28%-2.98%-10.25%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.74
5.79
5.91
6.37
7.30
3.53
3.22
4.54
2.79
3.14
4.87
6.68
Quick Ratio
3.66
4.67
4.87
5.24
6.19
2.34
2.40
3.37
2.18
2.50
3.55
4.79
Working Capital
38.62M
45.40M
52.84M
43.28M
46.59M
17.35M
23.01M
26.78M
29.86M
32.41M
28.74M
31.72M
Leverage & Debt
Debt to Equity
7.05
3.96
2.49
2.80
2.18
0.50
0.54
0.39
0.64
0.55
1.01
0.82
Interest Coverage TTM
-9.30
-11.56
-22.82
-17.71
-23.80
-23.77
-22.63
-25.51
-29.53
-54.70
-58.15
-58.60
Debt Ratio
0.88
0.80
0.71
0.74
0.69
0.34
0.35
0.28
0.39
0.36
0.50
0.45
Efficiency & Turnover
Asset Turnover TTM
0.57
0.66
0.54
0.68
0.58
0.77
0.77
0.72
0.56
0.50
0.49
0.44
Days Sales Outstanding TTM
54.63
55.33
55.59
41.86
42.02
34.89
46.07
37.78
40.79
36.20
44.77
47.71
Receivables Turnover TTM
6.68
6.60
6.57
8.72
8.69
10.46
7.92
9.66
8.95
10.08
8.15
7.65
Per Share Metrics
Diluted EPS TTM
-1.15
-0.98
-0.90
-0.81
-0.79
-0.75
-0.70
-0.66
-0.65
-0.81
-0.90
-0.89
Free Cash Flow Per Share TTM
-1.04
-0.90
-0.86
-0.49
-0.41
-0.42
-0.34
-0.32
-0.35
-0.49
-0.59
-0.66
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
62.61%
62.33%
61.38%
61.31%
60.42%
61.20%
60.92%
60.38%
59.85%
57.10%
56.83%
58.10%
Operating Profit Margin TTM
-73.42%
-65.20%
-65.36%
-66.28%
-67.39%
-67.26%
-62.87%
-61.80%
-66.06%
-80.08%
-93.70%
-99.51%
Net Profit Margin TTM
-81.76%
-71.57%
-69.08%
-67.40%
-66.15%
-64.51%
-60.25%
-59.64%
-64.06%
-78.84%
-92.21%
-97.92%
Growth Metrics
Net Revenue Growth (1Y)
25.86%
25.99%
17.78%
12.83%
19.68%
23.22%
31.04%
36.34%
29.33%
24.86%
16.56%
13.53%
Net Income Growth (1Y)
55.54%
39.78%
35.03%
27.51%
23.58%
0.81%
-14.37%
-16.97%
-13.69%
14.05%
34.40%
34.92%
EPS Growth (1Y)
45.70%
31.13%
28.89%
23.76%
20.13%
-7.43%
-22.05%
-25.88%
-22.75%
10.16%
32.09%
34.19%
Valuation Metrics
P/E TTM
-15.57
-9.25
-15.17
-26.77
-15.18
-15.85
-21.98
-17.04
-8.23
-8.39
-7.56
-5.65
P/B TTM
49.94
14.27
13.82
39.02
17.09
16.49
16.37
10.67
4.61
5.00
7.89
5.12
P/S TTM
12.73
6.62
10.48
18.04
10.04
10.22
13.24
10.16
5.27
6.62
6.97
5.53
Market Cap
538.17M
268.88M
387.35M
619.44M
337.40M
329.58M
415.69M
309.30M
148.05M
173.07M
167.07M
123.40M
Enterprise Value
558.12M
282.00M
389.46M
610.42M
324.53M
317.19M
395.58M
287.73M
125.19M
147.69M
153.88M
108.99M
Calculated Values
Free Cash Flow TTM
-31.29M
-26.70M
-24.45M
-13.82M
-11.72M
-11.74M
-9.23M
-8.91M
-9.73M
-12.46M
-14.44M
-16.35M
Net Debt
19.94M
13.13M
2.10M
-9.02M
-12.88M
-12.39M
-20.10M
-21.57M
-22.87M
-25.39M
-13.19M
-14.41M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-17Sale
Owner: Burnett, Joseph
Title: CEO and President
Shares: 60,000
Price/Share: $17.79
Value: $1,067,400.00
Shares Owned: 116,842
Relationship: Director,Officer
Ownership: Direct
2026-06-01Sale
Owner: Richards, Timothy T.
Title: -
Shares: 5,415
Price/Share: $12.17
Value: $65,900.55
Shares Owned: 87,198
Relationship: Director
Ownership: Direct
2026-05-21Sale
Owner: Klein, Matthew B.
Title: -
Shares: 16,000
Price/Share: $11.59
Value: $185,440.00
Shares Owned: 46,935
Relationship: Director
Ownership: Direct
2026-05-20Sale
Owner: Fallon, Lynnette C
Title: -
Shares: 5,091
Price/Share: $11.14
Value: $56,713.74
Shares Owned: 48,227
Relationship: Director
Ownership: Direct
2026-02-25Sale
Owner: Burnett, Joseph
Title: CEO and President
Shares: 19,951
Price/Share: $15.17
Value: $302,656.67
Shares Owned: 193,231
Relationship: Director,Officer
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
42.01%
Inst. Shares: 12,413,842
Shares Outstanding: 29,546,889
2025-12-31
39.70%
Inst. Shares: 11,240,328
Shares Outstanding: 28,315,254
2025-09-30
34.71%
Inst. Shares: 9,867,876
Shares Outstanding: 28,427,574
2025-06-30
31.75%
Inst. Shares: 8,971,377
Shares Outstanding: 28,258,305
2025-03-31
27.93%
Inst. Shares: 7,741,157
Shares Outstanding: 27,718,918

ClearPoint Neuro, Inc. (CLPT) — SEC Financial Statements & Analysis

ClearPoint Neuro, Inc. (CLPT) is a surgical & medical instruments & apparatus company, incorporated in DE. ClearPoint Neuro, Inc. trades on Nasdaq as: CLPT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ClearPoint Neuro, Inc. reported a 25.86% year-over-year revenue growth, a Gross Profit Margin of 62.61% (TTM), a Debt-to-Equity ratio of 7.05x, a Price-to-Sales (P/S) ratio of 12.73x (TTM), a Price-to-Book (P/B) ratio of 49.94x (TTM), at a market cap of $538.17M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
25.86%
Gross Profit Margin TTM
62.61%
Debt To Equity
7.05x
P/S TTM
12.73x
P/B TTM
49.94x
Market Cap
$538.17M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ClearPoint Neuro, Inc. in?

ClearPoint Neuro, Inc. (CLPT) operates in the Surgical & Medical Instruments & Apparatus industry.

What is CLPT's market cap?

ClearPoint Neuro, Inc. (CLPT) has a market capitalization of $538.17M as of 2026-06-30.

What exchange does CLPT trade on?

ClearPoint Neuro, Inc. (CLPT) trades on the Nasdaq.

Where is ClearPoint Neuro, Inc. incorporated?

ClearPoint Neuro, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.